Regulation of Ras through the Ras GRF exchange factor
Regulation of Ras through the Ras GRF exchange factor
批准号:
6724912
负责人:
RAYMOND R MATTINGLY
金额:
$19.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-01 至 2006-03-31
关键词:
G proteinbiological signal transductioncalcium ioncalmodulincerebral cortexenzyme activityguanine nucleotide binding proteinguanine nucleotide exchange factorsguanosine triphosphatehippocampusintermolecular interactionlaboratory rabbitlaboratory ratmass spectrometrymitogen activated protein kinasephosphorylationreceptor couplingserinesite directed mutagenesis
中文摘要
申请人描述:RAS的异常激活是导致
人类癌症。RAS-GRF1交换因子,它激活RAS以响应
G蛋白偶联受体,在中枢神经元中高度表达并发挥作用
在建立记忆的过程中起着至关重要的作用。RAS-GRF1基因的过表达
在人类肿瘤中,这种交换因子与癌症的发生有关。活动
RAS-GRF1的表达至少部分受其基因改变的控制
磷酸化状态,但其调控的详细图景尚未
已实现。这个项目的长期目标是获得一个详细的
对血管紧张素转换酶的生理和药理学意义
RAS-GRF交换系数。这项提案的目标是确定如何
Ras-GRF1交换因子受磷酸化调控。中环
假设RAS-GRF1是信号转导的关键整合因子
通过磷酸化和与之相互作用来调节其活性
钙/钙调蛋白。这项提议的基本原理是,通过定义
在控制RAS-GRF1的机制中,我们将对
新的和生理上重要的RAS激活途径。这个项目将
在非常有利于其成功的环境中演出
通过出色的大学互动和实质性的
机构承诺。这项建议的目的将会达到
通过对中心假设的三个具体目的进行检验:1)确定
RAS-GRFI中受调控的磷酸化位点。需要检验的假设是
G需要一系列磷酸化事件的组合
Ras-GRF1的蛋白依赖性激活。2).定义控制的集成
通过磷酸化和钙信号转导Ras-GRF1。RAS-GRF1的功能
将测试将多个信号集成到RAS的激活。
3).确定Ras-GRFI在丝氨酸-916处的磷酸化的双重作用。这个
工作假说是丝氨酸-916是一个具有生理意义的部位
调节的磷酸化,有助于激活和
下调汇率因素。
拟议的研究具有创新性,因为它们解决了一个重要的机制
对于中枢神经系统中RAS的激活,受到的研究较少。这个
结果将是重要的,因为它们将提供对
通过G蛋白偶联受体控制RAS,从而可能导致
为癌症干预确定新的治疗靶点。这个
结果很可能对我们理解
RAS/MAP激酶系统在学习和记忆中的作用
英文摘要
APPLICANT'S DESCRIPTION: Aberrant activation of Ras is a major contributor to
human cancer. The Ras-GRF1 exchange factor, which activates Ras in response to
G protein-coupled receptors, is highly expressed in central neurons and plays
an essential role in the establishment of memory. Over-expression of Ras-GRF1
in human tumors implicates this exchange factor in carcinogenesis. The activity
of Ras-GRF1 is controlled, at least in part, by alterations in its
phosphorylation state, but a detailed picture of its regulation has not been
achieved. The long-range goal of this project is to obtain a detailed
understanding of the physiological and pharmacological significance of the
Ras-GRF exchange factors. The objective of this proposal is to determine how
the Ras-GRF1 exchange factor is controlled by phosphorylation. The central
hypothesis is that Ras-GRF1 serves as a key integrator of signal transduction
by regulation of its activity through both phosphorylation and interaction with
calcium/calmodulin. The rationale for this proposal is that, through definition
of the mechanisms that control Ras-GRF1, we will produce greater insight into a
new and physiologically important pathway for Ras activation. This project will
be performed in an environment that is very favorable for its successful
completion through excellent collegial interactions and substantial
institutional commitment. The objective of this proposal will be attained
through testing the central hypothesis in three specific aims: 1).Determine the
sites of regulated phosphorylation in Ras-GRFI. The hypothesis to be tested is
that a combination of phosphorylation events is required for G
protein-dependent activation of Ras-GRF1. 2).Define the integration of control
of Ras-GRF1 by phosphorylation and calcium signaling. The ability of Ras-GRF1
to integrate multiple signals into the activation of Ras will be tested.
3).Elucidate a dual role for phosphorylation of Ras-GRFI at Serine-916. The
working hypothesis is that Serine-916 is a physiologically significant site of
regulated phosphorylation that contributes to both activation and
down-regulation of the exchange factor.
The proposed studies are innovative in that they address an important mechanism
for Ras activation in the CNS that has been subject to less investigation. The
results will be significant as they will provide key understanding of the
control of Ras by G protein-coupled receptors, and thus may potentially lead to
the identification of new therapeutic targets for intervention in cancer. The
results are likely to be of fundamental importance to our comprehension of the
role of the Ras/MAP kinase system in learning and memory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8665529
-
项目类别:
-
资助金额:$5.46万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:7666266
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:7531616
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8073003
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8396645
-
项目类别:
-
资助金额:$9.21万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:7849609
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8244681
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:7931069
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8072463
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8267714
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
-
批准号:8322889
-
项目类别:
-
资助金额:$7.69万
-
财政年份:2008
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Regulation of Ras through the Ras GRF exchange factor
-
批准号:6330723
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2001
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Regulation of Ras through the Ras GRF exchange factor
-
批准号:6878501
-
项目类别:
-
资助金额:$19.87万
-
财政年份:2001
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Regulation of Ras through the Ras GRF exchange factor
-
批准号:6513528
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2001
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
Regulation of Ras through the Ras GRF exchange factor
-
批准号:6633376
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2001
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
ONCOGENIC SIGNAL TRANSDUCTION & THE RAS GAP SH3 DOMAIN
-
批准号:2397396
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1996
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
ONCOGENIC SIGNAL TRANSDUCTION AND THE RAS-GAP SH3 DOMAIN
-
批准号:2105880
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1996
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
ONCOGENIC SIGNAL TRANSDUCTION AND THE RAS-GAP SH3 DOMAIN
-
批准号:2105879
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1995
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
ONCOGENIC SIGNAL TRANSDUCTION AND THE RAS-GAP SH3 DOMAIN
-
批准号:2105878
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1994
-
负责人:RAYMOND R MATTINGLY
-
依托单位:
海外基金